<DOC>
	<DOCNO>NCT02235610</DOCNO>
	<brief_summary>The overall objective study evaluate clinical effectiveness novel technique donor EVLP increase lung transplant activity allow previously unusable donor lung safely use clinical lung transplantation . Furthermore , utilize EVLP technique research setting thus allow evaluation inflammatory molecule ( biomarkers ) would benefit successful pre-conditioning increase knowledge lung inflammatory response transplantation .</brief_summary>
	<brief_title>Use Ex Vivo Lung Perfusion ( EVLP ) Reconditioning Marginal Donor Lungs Transplantation</brief_title>
	<detailed_description>Human donor lung meet standard clinical criterion donor lung utilization fit study inclusion criterion retrieve donor use current donor lung retrieval technique . These lung bring study transplant centre perfuse system transplant team . Perfusion lung perform use evaluation solution addition red blood cell cross match recipient , heparin antibiotic . Those lung perfusion system meet normal transplantation criterion consider transplantation . Lungs exclude transplantation organ n't meet normal transplantation criterion .</detailed_description>
	<criteria>Adult patient ( age 18 year ) . Patients already add active wait list first lung transplant . Patients provide informed consent participation study time study commencement time list transplant . Patients ' reconfirmation inform consent study day lung transplant . Patients age less 18 year . Patients provide informed consent study . Patients possession patient information sheet study prior day lung transplant . Patients ' reconfirm consent study day lung transplant . Patients require invasive mechanical ventilation , extracorporeal membrane oxygenation ( ECMO ) support .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Lung Transplantation</keyword>
	<keyword>Ex Vivo Lung Perfusion</keyword>
	<keyword>EVLP</keyword>
</DOC>